Ranitidine
Oral
Intravenous
Intramuscular
Class
Acid suppression agents
Subclass
H2-antihistamines
Substance name
raNITIdine hydrochloride
Common formulations
Tablet
Dosage and administration
Adults patients
No dosages available
Other off-label uses
Indications for use
Labeled indications
Adults
Children
Off-label indications
Adults
Safety risks
Contraindications
A known hypersensitivity to Ranitidine
Pre-existing acute porphyria
Warnings and precautions
Exacerbation of peptic ulcer disease
Vitamin B12 deficiency
Specific populations
Renal impairment
eGFR 20-50 mL/min/1.73 m²
eGFR 10-20 mL/min/1.73 m²
eGFR < 10 mL/min/1.73 m²
Renal replacement therapy
Continuous renal replacement
Intermittent hemodialysis
Peritoneal dialysis
Hepatic impairment
Any severity
Pregnancy and breastfeeding
Pregnancy
All trimesters • Australia Category: B1
Breastfeeding
Do not use during breastfeeding.
Unknown amount excreted in breastmilk.
Unknown drug levels in breastfed infants.
Unlikely to cause adverse effects in breastfed infants.
Some adverse effects on lactation reported.
Adverse reactions
Common 1-10%
Rare < 0.1%
Unknown frequency
Interactions
Drug(s)
Check Interactions
Reset
What did you think about this content?
Sign up for free to access the full drug resource